PL3565570T3 - Kompozycja - Google Patents

Kompozycja

Info

Publication number
PL3565570T3
PL3565570T3 PL18701798.3T PL18701798T PL3565570T3 PL 3565570 T3 PL3565570 T3 PL 3565570T3 PL 18701798 T PL18701798 T PL 18701798T PL 3565570 T3 PL3565570 T3 PL 3565570T3
Authority
PL
Poland
Prior art keywords
composition
Prior art date
Application number
PL18701798.3T
Other languages
English (en)
Inventor
Keith Martin
Liselotte Jansson
Original Assignee
Worg Pharmaceuticals (Zhejiang) Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Worg Pharmaceuticals (Zhejiang) Co., Ltd. filed Critical Worg Pharmaceuticals (Zhejiang) Co., Ltd.
Publication of PL3565570T3 publication Critical patent/PL3565570T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/10—Animals modified by protein administration, for non-therapeutic purpose
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0325—Animal model for autoimmune diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0368—Animal model for inflammation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0387—Animal model for diseases of the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Environmental Sciences (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Transplantation (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL18701798.3T 2017-01-04 2018-01-04 Kompozycja PL3565570T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1700095.1A GB201700095D0 (en) 2017-01-04 2017-01-04 Composition
PCT/IB2018/050062 WO2018127829A1 (en) 2017-01-04 2018-01-04 Composition

Publications (1)

Publication Number Publication Date
PL3565570T3 true PL3565570T3 (pl) 2024-11-04

Family

ID=58463667

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18701798.3T PL3565570T3 (pl) 2017-01-04 2018-01-04 Kompozycja

Country Status (11)

Country Link
US (2) US20190330294A1 (pl)
EP (1) EP3565570B1 (pl)
JP (2) JP7632996B2 (pl)
AU (1) AU2018206357B2 (pl)
CA (1) CA3049180A1 (pl)
ES (1) ES2984670T3 (pl)
GB (1) GB201700095D0 (pl)
HU (1) HUE068379T2 (pl)
PL (1) PL3565570T3 (pl)
WO (1) WO2018127829A1 (pl)
ZA (1) ZA201904385B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201919222D0 (en) * 2019-12-23 2020-02-05 Apitope Int Nv Composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1918298T3 (da) * 2000-08-21 2010-11-29 Apitope Technology Bristol Ltd Peptid
CA2445640A1 (en) * 2001-03-23 2002-10-03 John Matsoukas Peptide analogues of myelin basic protein epitopes in the treatment of experimental autoimmune encephalomyelitis (eae) and multiple sclerosis (ms)
US20140105980A1 (en) 2012-10-11 2014-04-17 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
CA2703170C (en) * 2007-10-31 2016-10-11 Apitope Technology (Bristol) Limited Composition comprising myelin basic proteins
HK1220368A1 (zh) * 2013-03-13 2017-05-05 Cour Pharmaceuticals Development Company 用於治疗炎症的免疫修饰性颗粒

Also Published As

Publication number Publication date
EP3565570A1 (en) 2019-11-13
US20250230207A1 (en) 2025-07-17
US20190330294A1 (en) 2019-10-31
AU2018206357A1 (en) 2019-07-18
JP2023027097A (ja) 2023-03-01
CA3049180A1 (en) 2018-07-12
ES2984670T3 (es) 2024-10-30
EP3565570B1 (en) 2024-07-03
ZA201904385B (en) 2023-04-26
HUE068379T2 (hu) 2024-12-28
GB201700095D0 (en) 2017-02-22
JP7679346B2 (ja) 2025-05-19
AU2018206357B2 (en) 2021-07-29
WO2018127829A1 (en) 2018-07-12
JP2020514288A (ja) 2020-05-21
JP7632996B2 (ja) 2025-02-19
EP3565570C0 (en) 2024-07-03

Similar Documents

Publication Publication Date Title
ZA202002723B (en) Composition
GB2562466B (en) Composition
GB201703455D0 (en) Composition
GB201707238D0 (en) Composition
GB201721846D0 (en) Novel composition
GB201721001D0 (en) Novel Composition
GB201715949D0 (en) Novel composition
GB201719139D0 (en) Composition
GB201700504D0 (en) Composition
GB201713636D0 (en) Composition
GB201702833D0 (en) Composition
PL3675653T3 (pl) Kompozycja przeciwmykotoksynowa
GB201519327D0 (en) Composition
GB201712151D0 (en) Composition
ZA202001300B (en) Novel composition
LT3576546T (lt) Probiotikų kompozicija
GB201721674D0 (en) Composition
GB201718871D0 (en) Composition
GB201711446D0 (en) Composition
GB201709905D0 (en) Composition
GB201707920D0 (en) Composition
ZA201904385B (en) Composition
GB201816988D0 (en) Composition
GB201715135D0 (en) Composition
GB201703457D0 (en) Composition